Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
---|---|---|---|---|---|
Gross Sales | 1,199.3 | 1,262.1 | 1,084.3 | 1,142.3 | 980.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,199.3 | 1,262.1 | 1,084.3 | 1,142.3 | 980.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 50.9 | 42.5 | 36.7 | 32.5 | 24.7 |
Total Income | 1,250.2 | 1,304.6 | 1,121 | 1,174.8 | 1,005.1 |
Total Expenditure | 876.3 | 889.6 | 799 | 818.3 | 751.8 |
PBIDT | 373.9 | 415 | 322 | 356.5 | 253.3 |
Interest | 10.3 | 12 | 13.6 | 15.8 | 18.1 |
PBDT | 363.6 | 403 | 308.4 | 340.7 | 235.2 |
Depreciation | 71.9 | 70 | 72.6 | 71 | 75.5 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 78.8 | 93.2 | 67 | 81 | 45.9 |
Deferred Tax | -40.7 | 1.2 | 0.8 | -5.6 | 3.3 |
Reported Profit After Tax | 253.6 | 238.6 | 168 | 194.3 | 110.5 |
Minority Interest After NP | 2.1 | 3 | 2.2 | 2.4 | 1 |
Net Profit after Minority Interest | 251.5 | 235.6 | 165.8 | 191.9 | 109.5 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 251.5 | 235.6 | 165.8 | 191.9 | 109.5 |
EPS (Unit Curr.) | 30.08 | 28.3 | 19.86 | 23.11 | 13.13 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 120 | 0 | 0 | 0 |
Equity | 83.6 | 83.6 | 83.5 | 83.5 | 83.4 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 31.17 | 32.88 | 29.69 | 31.2 | 25.83 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 21.14 | 18.9 | 15.49 | 17 | 11.27 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.